Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema

NCT01787669 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Diabetic Macular Oedema
Diabetic Macular Edema
Diabetic Retinopathy

Interventions

DRUG: Avastin (Bevacizumab)
DRUG: Ozurdex (dexamethasone)

Sponsor

University of Sydney

Collaborators

[object Object]